ABOUT US
HIGHGATE Genetics has a mission to expand cancer genetics services by making providers the drivers of testing and management of families. Genetic testing should become part of the oncology patient clinic visit, with follow-up conducted by a oncology practitioner in the presence of positive test results or significant family history. In parallel, many patients are well-served when paired with standard genetic cancer risk services.
Getting the right set of services for each cancer care practice or service can be a complex undertaking. HIGHGATE Genetics provides consultative services for program development, cancer genetics education, and business planning. The company is based in Augusta, Georgia, in the United States, and was founded by John W Henson, MD. Dr. Henson is the director of the Hereditary Cancer Clinic at the Georgia Cancer Center in Augusta and a professor at the Medical College of Georgia.
See About Dr. Henson, below.
Contact Us
Email
contact@highgategenetics.com
Physical Mail
HIGHGATE Genetics, LLC
PO Box 2105
Augusta, GA 30903
ABOUT DR. HENSON
Biographical Information
John W. Henson, MD, FAAN
Dr. Henson attended college at Southern Adventist University in Collegedale, TN, and medical school at Loma Linda University School of Medicine in California. Following a residency in Neurology under Gerald Fenichel, M.D. at Vanderbilt University Medical Center, Dr. Henson completed a 3-year fellowship in Neuro-oncology at Memorial Sloan-Kettering Cancer Center with William Shapiro, MD, Jerome Posner, MD, and Henry Furneaux, PhD. He joined the staff of the Neurology Service at Massachusetts General Hospital in 1991, where he worked until 2008 as Associate Professor of Neurology at Harvard Medical School and Associate Neurologist at the Massachusetts General Hospital.
In 2001 Dr. Henson further broadened his professional work by embarking on a 2-year fellowship in diagnostic neuroradiology at the MGH. In 2003 he became a staff member in the MGH Department of Radiology.
He became chief of neurology at the Swedish Neuroscience Institute in Seattle, building that program to over 50 subspecialists. Following an executive MBA at the Foster School of Business at the University of Washington, he was appointed vice president of medical affairs at Swedish. In 2015 he was appointed chief of oncology services for Piedmont Healthcare. Dr. Henson took the Intensive Course in Cancer Genetic Risk Analysis at City of Hope under Dr. Jeffrey Weitzal.
In 2021 he joined the Medical College of Georgia as professor, and launched the Hereditary Cancer Clinic.
Dr. Henson has had a productive academic record, including federal funding, and site investigator and chair of the Pipeline Development Committee for NINDS-sponsored NeuroNEXT consortium. He has published 125 papers, reviews, and book chapters in the fields of cancer genetics, neuro-oncology, neurovirology, and neuroimaging. He coauthored the text “Diagnosis and Management of Hereditary Cancer” in 2021. His second textbook, titled “Encyclopedia of Hereditary Cancer”, is due out in the Spring of 2024 and is available for pre-purchase from Elsevier and Amazon.
